Advances in Multiple Sclerosis and Experimental Demyelinating Diseases

"There is a need for a paradigm shift in our thinking about the pathogenesis of multiple sclerosis." Challenging Charcot’s hypothesis that inflammatory response is the primary contributor to demyelination, Dr. Rodriguez and colleagues take a fresh, bold look at the causes and possible trea...

Full description

Corporate Author: SpringerLink (Online service)
Other Authors: Rodriguez, Moses. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Language:English
Published: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2008.
Edition:1st ed. 2008.
Series:Current Topics in Microbiology and Immunology, 318
Subjects:
Online Access:https://doi.org/10.1007/978-3-540-73677-6
LEADER 04393nam a22004935i 4500
001 978-3-540-73677-6
003 DE-He213
005 20210609141158.0
007 cr nn 008mamaa
008 100301s2008 gw | s |||| 0|eng d
020 |a 9783540736776  |9 978-3-540-73677-6 
024 7 |a 10.1007/978-3-540-73677-6  |2 doi 
050 4 |a RC346-429.2 
072 7 |a MJN  |2 bicssc 
072 7 |a MED056000  |2 bisacsh 
072 7 |a MKJ  |2 thema 
082 0 4 |a 616.8  |2 23 
245 1 0 |a Advances in Multiple Sclerosis and Experimental Demyelinating Diseases  |h [electronic resource] /  |c edited by Moses Rodriguez. 
250 |a 1st ed. 2008. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg :  |b Imprint: Springer,  |c 2008. 
300 |a XIV, 362 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Current Topics in Microbiology and Immunology,  |x 0070-217X ;  |v 318 
505 0 |a Benign Multiple Sclerosis: A Distinct Clinical Entity with Therapeutic Implications -- Pathological Heterogeneity of Idiopathic Central Nervous System Inflammatory Demyelinating Disorders -- Multiple Sclerosis Genetics -- Imaging of Remyelination and Neuronal Health -- Immunological Aspects of Axon Injury in Multiple Sclerosis -- The Multiple Sclerosis Degradome: Enzymatic Cascades in Development and Progression of Central Nervous System Inflammatory Disease -- Genetic Analysis of CNS Remyelination -- Remyelination in Experimental Models of Toxin-Induced Demyelination -- Remyelination-Promoting Human IgMs: Developing a Therapeutic Reagent for Demyelinating Disease -- Neuroimaging of Demyelination and Remyelination Models -- Hormonal Influences in Multiple Sclerosis -- Statins and Demyelination -- Role of Uric Acid in Multiple Sclerosis -- Neuromyelitis Optica: Clinical Syndrome and the NMO-IgG Autoantibody Marker. 
520 |a "There is a need for a paradigm shift in our thinking about the pathogenesis of multiple sclerosis." Challenging Charcot’s hypothesis that inflammatory response is the primary contributor to demyelination, Dr. Rodriguez and colleagues take a fresh, bold look at the causes and possible treatments of MS. Assuming oligodendrocyte injury as a prerequisite to MS, the authors explore viruses, toxins and genetic defects as possible culprits. They present novel methods to interrupt and reverse demyelination. This book examines the correlation between axonal loss and clinical deficits, including the implied role of the CD8+ T cell and perforin. It assesses proteases, specifically, kallikrein 6, which are strongly associated with active demyelination. By directing natural autoantibodies against oligodendrocytes that demonstrate remyelination in animal models, the authors envision clinical trials for remyelination enhancement. As internationally recognized specialists in a wide range of MS disciplines, the authors explore genetic tools for identifying patients who are most likely to experience spontaneous remyelination. Epidemiology studies offer additional avenues of treatment. Examples include uric acid, statin drugs, estrogen and progesterone. MS affects nearly 400,000 people in the United States, many of whom are between18 and 40 years of age. With their novel, multifaceted approach to basic science—and their applications in understanding cause and treatment—the authors offer help to clinicians and hope to patients. 
650 0 |a Neurology . 
650 0 |a Immunology. 
650 1 4 |a Neurology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/H36001 
650 2 4 |a Immunology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/B14000 
700 1 |a Rodriguez, Moses.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783540841098 
776 0 8 |i Printed edition:  |z 9783540736769 
776 0 8 |i Printed edition:  |z 9783642437830 
830 0 |a Current Topics in Microbiology and Immunology,  |x 0070-217X ;  |v 318 
856 4 0 |u https://doi.org/10.1007/978-3-540-73677-6 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)